It was a real pleasure sharing the session with you. Thank you so much for helping me feel comfortable in my first presentation at EAN.
24.06.2025 07:59
👍 2
🔁 0
💬 0
📌 0
It was a real pleasure sharing the session with you. Thank you so much for helping me feel comfortable in my first presentation at EAN.
IL-10 in Systemic Lupus Erythematosus: Balancing Immunoregulation and Autoimmunity
🔑involved in inflammatory and immune processes in SLE.
🔹IL-10 did not correlate with disease activity, organ in-
volvement, or treatment response.
www.mdpi.com/1422-0067/26...
🔶Treat-to-target in SLE: is serology important? Results from an integrated analysis of five randomized clinical trials of five randomized clinical trials of belimumab
🔹🔹Normal serology enhances the protection of DORIS and LLDAS against severe and renal SLE flares
academic.oup.com/rheumatology...
It has been a great pleasure to present our preliminary results on the role of HLA DQ2/DQ8 in the pathogenesis of idiopathic encephalitis, myelitis, and optic neuritis at #ACTRIMS2025 🧠 #Neurology @UNIEMTGirona
Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review
#myopathies
academic.oup.com/rheumatology...
Conducting a real-world study of Tumor Necrosis factor-alpha inhibitors-induced Systemic Lupus Erythematosus based on the FAERS database
〰️Different TNF-α inhibitors should be continuously monitored for SLE-induced complications
www.nature.com/articles/s41...
Sexual experience and functioning in male and female patients with #Sjögren’s disease: a qualitative study
🔸 64% of women & 67% of men reported dysfunction.
🔸 Chronic stress, invisible suffering & relationship dynamics highlight the need for holistic care.
rmdopen.bmj.com/content/11/1...
Palau de la Generalitat in red #Girona
Me, in red!
Thanks @gencat #Girona for illuminating El Pati de les Magnòlies in red, joining our city to the campaign for the #WorldEncephalitisDay #RED4WED.
Some of our patients are affected by this serious condition which needs visibility to raise public awareness. 🧠🔴 #Girona #Spain
2025 update on clinical trials in immune thrombocytopenia
#ITP #Thrombocytopenia #Future #Science #ClinicalTrial
onlinelibrary.wiley.com/doi/full/10....
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: Consensus statements from an international task force
#SLE #T2T
www.sciencedirect.com/science/arti...
The ACPE-Gi score was a reliable scale for comprehensively assessing the severity of AE and predicting the risk of disability at 3 months
#Dysautonomia and altered mental status independently predicted a poorer prognosis in patients with AE www.frontiersin.org/journals/psy...
We identified that the mean initial score was significantly higher in the group of patients who had higher mRS at 3 months compared to the other groups. In addition, autonomic symptoms and mental status impairment demonstrated to be independent risk factors to predict disability
ACPE-Gi score measured the severity in the acute phase and grouped the patients into three groups: mild (<8; 32%), moderate (8 to 15; 60%), and severe (>15; 8%). We found that the third group had a higher risk of disability compared with the first group.
Patients were strictly diagnosed with AE according to the current criteria between 1 January 2009 to 31 March 2023 at @htrueta. ACPE-Gi score included 14 items, and every item was scored from 0 to 3, depending on their severity with a sum ranging from 0 to 41.
We are excited to share our last paper on #AutoimmuneEncephalitis (AE)‼️ 🧠
The assessment of clinical prognosis in autoimmune encephalitis: Girona score (ACPE-Gi) assesses the severity in the acute phase of AE and predicting the risk of disability at 3 months, measured by mRS